THE CIGNA GROUP (CI) Stock Price & Overview

NYSE:CI • US1255231003

Current stock price

262.84 USD
-1.73 (-0.65%)
At close:
265.02 USD
+2.18 (+0.83%)
After Hours:

The current stock price of CI is 262.84 USD. Today CI is down by -0.65%. In the past month the price decreased by -6.23%. In the past year, price decreased by -16.99%.

CI Key Statistics

52-Week Range239.51 - 350
Current CI stock price positioned within its 52-week range.
1-Month Range258.14 - 292.32
Current CI stock price positioned within its 1-month range.
Market Cap
69.266B
P/E
8.81
Fwd P/E
8.41
EPS (TTM)
29.85
Dividend Yield
2.35%

CI Stock Performance

Today
-0.65%
1 Week
-1.63%
1 Month
-6.23%
3 Months
-3.33%
Longer-term
6 Months -9.48%
1 Year -16.99%
2 Years -27.63%
3 Years +2.86%
5 Years +8.73%
10 Years +91.52%

CI Stock Chart

THE CIGNA GROUP / CI Daily stock chart

CI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to CI. When comparing the yearly performance of all stocks, CI is a bad performer in the overall market: 74.83% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CI. CI has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CI Earnings

On February 5, 2026 CI reported an EPS of 8.08 and a revenue of 72.47B. The company missed EPS expectations (-0.41% surprise) and beat revenue expectations (0.76% surprise).

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 5, 2026
PeriodQ4 / 2025
EPS Reported$8.08
Revenue Reported72.472B
EPS Surprise -0.41%
Revenue Surprise 0.76%

CI Forecast & Estimates

33 analysts have analysed CI and the average price target is 340.16 USD. This implies a price increase of 29.42% is expected in the next year compared to the current price of 262.84.

For the next year, analysts expect an EPS growth of 4.65% and a revenue growth 4.17% for CI


Analysts
Analysts82.42
Price Target340.16 (29.42%)
EPS Next Y4.65%
Revenue Next Year4.17%

CI Groups

Sector & Classification

CI Financial Highlights

Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 29.85. The EPS increased by 9.18% compared to the year before.


Income Statements
Revenue(TTM)274.90B
Net Income(TTM)5.96B
Industry RankSector Rank
PM (TTM) 2.17%
ROA 3.77%
ROE 14.28%
Debt/Equity 0.74
Chartmill High Growth Momentum
EPS Q2Q%21.69%
Sales Q2Q%10.39%
EPS 1Y (TTM)9.18%
Revenue 1Y (TTM)11.24%

CI Ownership

Ownership
Inst Owners91.11%
Shares263.53M
Float257.88M
Ins Owners0.34%
Short Float %2.02%
Short Ratio3

About CI

Company Profile

CI logo image The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 67,700 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Company Info

IPO: 1982-04-01

THE CIGNA GROUP

900 Cottage Grove Road

Bloomfield CONNECTICUT 06002 US

CEO: David M. Cordani

Employees: 72398

CI Company Website

CI Investor Relations

Phone: 13026587581

THE CIGNA GROUP / CI FAQ

What does CI do?

The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 67,700 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.


What is the stock price of THE CIGNA GROUP today?

The current stock price of CI is 262.84 USD. The price decreased by -0.65% in the last trading session.


Does THE CIGNA GROUP pay dividends?

THE CIGNA GROUP (CI) has a dividend yield of 2.35%. The yearly dividend amount is currently 6.


What is the ChartMill technical and fundamental rating of CI stock?

CI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Which stock exchange lists CI stock?

CI stock is listed on the New York Stock Exchange exchange.


What is the analyst forecast for CI stock?

33 analysts have analysed CI and the average price target is 340.16 USD. This implies a price increase of 29.42% is expected in the next year compared to the current price of 262.84.


Is THE CIGNA GROUP (CI) expected to grow?

The Revenue of THE CIGNA GROUP (CI) is expected to grow by 4.17% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.